Product Lead, Regulatory Innovation (AI)
- Location
- Greater London, England, United Kingdom
late-stage clinical trials. Its products operate at the intersection of several regulatory regimes, including IVDR, MDR/SaMD, ICH E6 (R3) GCP, 21 CFR Part 11, the EU AI Act, and the emerging FDA and EMA frameworks for AI in drug development. Responsibilities Lean (QMS) process advocacy Partner … relation to AI for both clinical practice and trials. Working knowledge of computerised system validation in clinical trials, ICH E6 (GCP), GAMP 5, ISO 13485, ISO 14971, IEC 62304 and 21 CFR Part 11. Familiarity with AI-specific quality and risk frameworks: FDA AI/ML SaMD ...